$4.95
-0.06-1.20%
At close: -
$5.05
0.12.02%
After Hours: 5:21 PM EDT
Arcadia Biosciences reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Arcadia Biosciences using advanced sorting and filters.
Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Q3 | 2024-11-12 | $-1.18 | $-0.81 | -45.7 % |
Q2 | 2024-08-13 | $0.78 | $1.55 | -49.7 % |
Q1 | 2024-05-09 | $-1.78 | $-2.21 | 19.5 % |
Q4 | 2024-03-28 | $-2.10 | $-2.58 | 18.6 % |
Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Q3 | 2024-11-12 | $1.54M | $1.40M | 9.79 % |
Q2 | 2024-08-13 | $1.31M | $920.00K | 42.0 % |
Q1 | 2024-05-09 | $1.25M | $1.19M | 5.46 % |
Q4 | 2024-03-28 | $1.17M | $1.75M | -33.1 % |
Arcadia Biosciences (RKDA) is scheduled to report earnings on March 27, 2025. The last reported earnings were for reported on November 12, 2024 for Q3.
The Actual EPS was $-1.18, which missed the estimate of $-0.81.
The Actual Revenue was $1.5M, which beat the estimate of $1.4M.
Browse earnings estimates, EPS, and revenue on all stocks.